ACTICOAT^◊ Site is an antimicrobial absorbent 3-layer dressing consisting of the following:

• A nanocrystalline silver-coated polyurethane wound contact layer
• a white polyurethane foam layer and
• a blue waterproof polyurethane film layer

The dressing provides an effective barrier to microbial contamination protecting the insertion site from invasive pathogenic microorganisms. Nanocrystalline silver is also effective against micro-organisms present in the wound.

ACTICOAT^◊ Site is indicated as a dressing for use around vascular and non-vascular percutaneous device sites such as intravenous catheter insertion sites and external fixation sites. ACTICOAT^◊ Site may be left in place for up to 7 days.

ACTICOAT^◊ Site may be used on infected insertion sites. Where the product is used on infected insertion sites, the infection should be inspected and treated as per local clinical protocol.

Contraindications

• Do not use on patients with a known sensitivity to silver
• Do not use on patients with a known sensitivity to polyurethane
• Do not use on patients during MRI (Magnetic Resonance Imaging) examination because the image at the dressing site may be distorted

Precautions

• For external use only 
• ACTICOAT^◊ Site is not compatible with oil-based products such as petrolatum
• ACTICOAT^◊ Site may not be compatible with topical antimicrobials
• ACTICOAT^◊ Site is not compatible with oxidising agents (eg. EUSOL) as these can breakdown the absorbent polyurethane component of the dressing
• Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
• Prior to administering radiation therapy, remove ACTICOAT^◊ Site. A new dressing can be applied following treatment
• If reddening or sensitisation occurs, discontinue use
• ACTICOAT^◊ Site should be removed prior to X-ray as it may obscure imaging

Product#	Size	Pcs/Pkg	Pkg/Case	HCPCS
20611	1 disk with 4mm central opening	10	10	A6209

™SILCRYST is a Trademark of NUCRYST Pharmaceuticals Corp. used under license.